M. Lehnert

发表

Expression of p21(Wafl/Cip1), p57(Kip2) and HER2/neu in patients with gallbladder cancer.

T. Gruenberger, D. Kandioler, M. Filipits, 2007, Anticancer research.

Second malignancies after ewing tumor treatment in 690 patients from a cooperative German/Austrian/Dutch study.

H. Hense, P. Voûte, G. Henze, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Population-based incidence estimates of uveal melanoma in Germany. Supplementing cancer registry data by case–control data

D. Parkin, K. Jöckel, A. Stang, 2006, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[Erythropoiesis stimulating proteins for the treatment of anemia in cancer patients].

M. Lehnert, H. Ludwig, S. Burger, 2010, Therapeutische Umschau. Revue therapeutique.

[Epidemiology of prostate cancer: recent results from the Epidemiological Cancer Register of the District of Münster (Germany)].

H. Hense, A. Semjonow, M. Lehnert, 2008, Der Urologe. Ausg. A.

Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients.

S. Clarke, B. Goh, M. Millward, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Once-weekly epoetin beta (30,000 IU) in anemic patients with lung cancer receiving chemotherapy.

R. Pirker, M. Lehnert, W. Minar, 2007, Lung cancer.

Cancer registration in Germany: current status, perspectives and trends in cancer incidence 1973-93.

C. Stegmaier, M. Lehnert, J. Schüz, 2000, Journal of epidemiology and biostatistics.

Update on the rational use of 90Y-ibritumomab tiuxetan in the treatment of follicular lymphoma

M. Lehnert, H. Ludwig, N. Zojer, 2009, OncoTargets and therapy.

Combined standard and novel immunosuppressive substances affect B-lymphocyte function.

K. Budde, M. Mashreghi, M. Matz, 2013, International immunopharmacology.

[Descriptive epidemiology of Ewing's tumor--analysis of German patients from (EI)CESS 1980-1997].

H. Hense, M. Lehnert, H. Jürgens, 1999, Klinische Padiatrie.

Cyclin D1 Expression in Breast Cancer Patients Receiving Adjuvant Tamoxifen-Based Therapy

R. Greil, M. Gnant, R. Jakesz, 2008, Clinical Cancer Research.

Phase II trial of docetaxel in Asian patients with inoperable stage III non-small cell lung cancer.

B. Goh, M. Lehnert, J. Wee, 2000, Acta oncologica.

Factors associated with tumor volume and primary metastases in Ewing tumors: results from the (EI)CESS studies.

H. Hense, H. Jürgens, M. Lehnert, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Effects of sotrastaurin, mycophenolic acid and everolimus on human B‐lymphocyte function and activation

N. Unterwalder, K. Budde, M. Mashreghi, 2012, Transplant international : official journal of the European Society for Organ Transplantation.

Outcome of a structured surveillance programme in women with a familial predisposition for breast cancer

Silke Coburger, Rita K Schmutzler, Kerstin Rhiem, 2006, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Characteristics and prognosis of KI-1 positive anaplastic large cell lymphoma in Asians.

M. Lehnert, Y. Kueh, Y. O. Tan, 1998, Australian and New Zealand journal of medicine.

Activated Mammalian Target of Rapamycin Is an Adverse Prognostic Factor in Patients with Biliary Tract Adenocarcinoma

T. Gruenberger, R. Pirker, M. Filipits, 2007, Clinical Cancer Research.

The prevalence of BRCA1 mutations in Chinese patients with early onset breast cancer and affected relatives

J. Sng, M. Lehnert, J. Wong, 2000, British Journal of Cancer.